duBois A - Search Results

1

Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.

Fotopoulou C, duBois A, Karavas AN, Trappe R, Aminossadati B, Schmalfeldt B, Pfisterer J, Sehouli J; Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group. Fotopoulou C, et al. Among authors: dubois a. J Clin Oncol. 2008 Jun 1;26(16):2683-9. doi: 10.1200/JCO.2008.16.1109. J Clin Oncol. 2008. PMID: 18509180

2

Therapeutic strategies in cervical pregnancy.

Dall P, Pfisterer J, du Bois A, Wilhelm C, Pfleiderer A. Dall P, et al. Eur J Obstet Gynecol Reprod Biol. 1994 Sep;56(3):195-200. doi: 10.1016/0028-2243(94)90170-8. Eur J Obstet Gynecol Reprod Biol. 1994. PMID: 7821493 Review.

3

Cellular DNA content and survival in advanced ovarian carcinoma.

Pfisterer J, Kommoss F, Sauerbrei W, Renz H, du Bois A, Kiechle-Schwarz M, Pfleiderer A. Pfisterer J, et al. Cancer. 1994 Nov 1;74(9):2509-15. doi: 10.1002/1097-0142(19941101)74:9<2509::aid-cncr2820740919>3.0.co;2-f. Cancer. 1994. PMID: 7923008

4

Phase II study of pirarubicin combined with cisplatin in recurrent ovarian cancer.

du Bois A, Meerpohl HG, Madjar H, Spinner D, Dall P, Pfisterer J, Bauknecht T. du Bois A, et al. J Cancer Res Clin Oncol. 1994;120(3):173-8. doi: 10.1007/BF01202198. J Cancer Res Clin Oncol. 1994. PMID: 8263015 Clinical Trial.

5

Paclitaxel-induced "recall" soft tissue ulcerations occurring at the site of previous subcutaneous administration of paclitaxel in low doses.

du Bois A, Kommoss FG, Pfisterer J, Lück HJ, Meerpohl HG. du Bois A, et al. Gynecol Oncol. 1996 Jan;60(1):94-6. doi: 10.1006/gyno.1996.0017. Gynecol Oncol. 1996. PMID: 8557235

6

Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer.

Luck HJ, Thomssen C, duBois A, Lisboa BW, Untch M, Kuhnle H, Konecny G, Janicke F, Meerpohl HG, Lindner C, Hecker D, Diergarten K. Luck HJ, et al. Among authors: dubois a. Semin Oncol. 1996 Feb;23(1 Suppl 1):33-6. Semin Oncol. 1996. PMID: 8629034 Clinical Trial.

7

Preliminary results of a phase II study of epirubicin and paclitaxel as first-line treatment in patients with metastatic breast cancer.

Lück HJ, Thomssen C, du Bois A, Lisboa BW, Untch M, Kühnle H, Jänicke F, Meerpohl HG, Lindner C, Konecny G, Hecker D, Diergarten K. Lück HJ, et al. Semin Oncol. 1997 Feb;24(1 Suppl 3):S13-6. Semin Oncol. 1997. PMID: 9071334 Clinical Trial.

8

Paclitaxel and epirubicin as first-line therapy for patients with metastatic breast cancer.

Lück HJ, Du Bois A, Thomssen C, Lisboa B, Untch M, Köhler G, Hecker D. Lück HJ, et al. Oncology (Williston Park). 1997 Apr;11(4 Suppl 3):34-7. Oncology (Williston Park). 1997. PMID: 9144689 Free article. Clinical Trial.

9

Extended phase II study of paclitaxel as a 3-h infusion in patients with ovarian cancer previously treated with plantinum.

du Bois A, Lück HJ, Buser K, Meerpohl HG, Sessa C, Klaassen U, Meden H, Bochtler H, Diergarten K. du Bois A, et al. Eur J Cancer. 1997 Mar;33(3):379-84. doi: 10.1016/s0959-8049(97)89009-0. Eur J Cancer. 1997. PMID: 9155520 Clinical Trial.

10

Phase I/II study of the combination of carboplatin and paclitaxel as first-line chemotherapy in patients with advanced epithelial ovarian cancer.

du Bois A, Lück HJ, Bauknecht T, Möbus V, Bochtler H, Diergarten K, Meerpohl HG. du Bois A, et al. Ann Oncol. 1997 Apr;8(4):355-61. doi: 10.1023/a:1008267419453. Ann Oncol. 1997. PMID: 9209665 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,049 results

Search Page